Chu, Shih-Chun A.
Hsiao, Yi https://orcid.org/0000-0002-9435-0305
Wang, Chenwei https://orcid.org/0000-0002-0920-8639
Kyle, Jennifer E.
Jain, Raghav https://orcid.org/0000-0002-1284-6762
Deng, Yamei https://orcid.org/0000-0002-3680-5930
Gritsenko, Marina A. https://orcid.org/0000-0001-9992-9829
Henry, Leanne E.
Lei, Jonathan T.
Dou, Yongchao
Tercan, Bahar
Shi, Zhiao
Gondal, Mahnoor N. https://orcid.org/0000-0002-9419-6758
Tsai, Chia-Feng https://orcid.org/0000-0002-6514-6911
Elizarraras, John M. https://orcid.org/0000-0001-7759-2540
Chu, Rosalie K.
Yu, Fengchao https://orcid.org/0000-0002-7695-3698
Joshi, Sunil K.
Jing, Xiaojun
Polasky, Daniel A. https://orcid.org/0000-0002-0515-1735
Weitz, Karl K.
Li, Ginny Xiaohe
Paurus, Vanessa L. https://orcid.org/0000-0002-8960-2926
Clendinen, Chaevien S. https://orcid.org/0000-0002-1487-4126
Schepmoes, Athena A.
Lalli, Priscila M.
Eder, Josie G.
Flores, Javier E. https://orcid.org/0000-0002-1550-1655
Stratton, Kelly G.
Pino, James C.
Posso, Camilo
Petyuk, Vladislav A.
Sagendorf, Tyler J.
Xu, Yuanwei https://orcid.org/0000-0001-7020-7961
Ibrahim, Omar M. https://orcid.org/0000-0002-9903-6657
Moore, Ronald J. https://orcid.org/0000-0003-2806-2855
Zhao, Rui
Chen, Jin
Monroe, Matthew E.
Thiagarajan, Mathangi
Hostetter, Galen
Newton, Chelsea
An, Eunkyung https://orcid.org/0000-0003-3096-9413
Robles, Ana I. https://orcid.org/0000-0001-5019-4374
Zhang, Xu
Edwards, Nathan J.
Lu, Yin
Zhang, Hui https://orcid.org/0000-0001-8726-7098
Abdelhakim, Haitham
Piehowski, Paul D. https://orcid.org/0000-0001-5108-2227
Mesri, Mehdi
Smith, Richard D.
Kumar-Sinha, Chandan https://orcid.org/0000-0002-8696-3400
Tognon, Cristina E.
Dunlap, Jennifer
Traer, Elie
Ding, Li https://orcid.org/0000-0003-1517-2975
Tyner, Jeffrey W. https://orcid.org/0000-0002-2133-0960
Chinnaiyan, Arul M. https://orcid.org/0000-0001-9282-3415
Omenn, Gilbert S. https://orcid.org/0000-0002-8976-6074
Rodland, Karin D.
Dhanasekaran, Saravana M.
Gosline, Sara J. C.
Nesvizhiskii, Alexey I. https://orcid.org/0000-0002-2806-7819
Zhang, Bing https://orcid.org/0000-0001-8676-2425
Liu, Tao https://orcid.org/0000-0001-9529-6550
Cieslik, Marcin P. https://orcid.org/0000-0002-5467-1040
,
Abts, Shelby
Agarwal, Anupriya
Baladandayuthapani, Veera
Basu, Anand
Belinda, Garana
Bocik, William
Borucki, Melissa
Cai, Shuang
Camelia, Stancioaica Maria
Carr, Steven
Castro, Patricia
Chan, Daniel
Cho, Hanbyul
Chu, Rosalie K.
Clendinen, Chaevien S.
Colantonio, Simona
Crispen, Reese
Davar, Diwaker
Dhir, Rajiv
Domagalski, Marcin
Evangelista, John
Fevrier-Sullivan, Brenda
Fonseca, Rafael
Freymann, John
Fulidou, Victoria
Gaheen, Sharon
Georgiev, Pencho
Getz, Gad
Gil, Lidia
Gillette, Michael A.
Godwin, Andrew K.
Goldthwaite, Charles A. Jr
Golubkov, Vladislav
Govindan, Ramaswamy
Green, Anthony
Holck, Michael
Hosseini, Noshad
Hsiao, Yi
Hsu, Joel
Huang, Lan
Ittmann, Michael
Jaehnig, Eric
Ketchum, Karen A.
Kirby, Justin
Kolodziejczak, Iga
Krutikova, Yelena V.
Le, Toan
Li, Qing Kay
Lih, T. Mamie
Ma’ayan, Avi
MacCoss, Micheal J.
Mangalaparthi, Kiran K.
Mani, D. R.
Mannan, Rahul
Mays, Monica
McGarvey, Peter
Noyama, James
Nyce, Kristen
Pandey, Akhilesh
Parolia, Abhijit
Paulovich, Amanda G.
Petralia, Francesca
Pico, Alex
Pilozzi, Alexander
Eser, Pinar O.
Potapova, Olga
Prilutskaya, Marina
Rivero, Gustavo
Rohrer, Dan
Rudnick, Paul
Satpathy, Shankha
Shutack, Yvonne
Garcia-Buntley, Sandra S.
Thangudu, Ratna R.
Thiagarajan, Mathangi
Tsai, Chia-Feng
Vatanian, Negin
Venkatachari, Sudha
Vucic, Miodrag
Wang, Chenwei
Wang, Pei
Wang, Yuefan
Williams, Bart O.
Wiznerowicz, Maciej
Xu, Yuanwei
Zaalishvili, Kakhaber
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 26 March 2025
Accepted: 21 April 2026
First Online: 12 June 2026
Competing interests
: J.W.T. has received research support from Aptose, AstraZeneca, Constellation, Genentech, Incyte, Kronos, Meryx and Schrödinger and serves on advisory boards for Recludix Pharma, AmMax Bio and Ellipses Pharma. A.I.N. is the founder of Fragmatics and serves on the scientific advisory boards of Protai Bio, Infinitopes and Mobilion Systems. A.I.N. is also a paid consultant for Novartis. A.I.N., F.Y. and D.A.P. have a financial interest because of the licensing of MSFragger, IonQuant and diaTracer to commercial entities. The other authors declare no competing interests.